BVF Inc
- SEC CIK
- 0001056807
- 最新申報
- 2026/8/14
2022 年第 1 季持倉
持倉截至 2022/3/31，2022/5/16 申報。只含多頭部位，變化是跟 2021 年第 4 季比股數。
- 持股檔數
- 81
- 較 2021 年第 4 季 −2
- 總值
- $25.0 億
- 較 2021 年第 4 季 −$2.55 億 (−9.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GHRSGH Research PLC | ORDINARY SHARES | 9,275,158 | $1.70 億 | 6.8% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 3,586,658 | $1.52 億 | 6.1% | +406,000+12.8% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 4,530,605 | $1.36 億 | 5.4% | +1,400,000+44.7% | 加碼 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 3,960,948 | $1.25 億 | 5.0% | +562,881+16.6% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 4,135,071 | $1.09 億 | 4.4% | 00.0% | 不變 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 316,204 | $9,970 萬 | 4.0% | +100,000+46.3% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 4,183,219 | $9,906 萬 | 4.0% | +531,460+14.6% | 加碼 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 3,530,543 | $9,879 萬 | 4.0% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 5,858,776 | $8,343 萬 | 3.3% | +1,000,015+20.6% | 加碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 3,976,543 | $6,856 萬 | 2.7% | +2,280,639+134.5% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,003,879 | $6,594 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,046,283 | $6,489 萬 | 2.6% | −110,110−9.5% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 5,369,459 | $5,622 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 3,203,783 | $5,152 萬 | 2.1% | +1,139,571+55.2% | 加碼 | 歷史 |
| EQRXEQRx, Inc. | COM | 12,025,570 | $4,967 萬 | 2.0% | +4,165,900+53.0% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,597,966 | $4,885 萬 | 2.0% | −1,691,574−51.4% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 1,810,549 | $4,619 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 1,400,201 | $4,506 萬 | 1.8% | +1,400,201 | 新進 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 1,647,400 | $4,446 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| CTICCti Biopharma Corp | COM | 8,929,690 | $4,170 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,394,714 | $4,162 萬 | 1.7% | +295,000+14.0% | 加碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,664,521 | $4,029 萬 | 1.6% | +658,659+32.8% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,744,012 | $3,225 萬 | 1.3% | −135,400−7.2% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 7,411,503 | $3,157 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 1,735,293 | $3,044 萬 | 1.2% | +1,735,293 | 新進 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 14,356,589 | $3,001 萬 | 1.2% | −3,4110.0% | 減碼 | 歷史 |
| ACIUAC Immune SA | SHS | 7,428,379 | $2,971 萬 | 1.2% | +366,000+5.2% | 加碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 3,447,946 | $2,834 萬 | 1.1% | +2,522,798+272.7% | 加碼 | 歷史 |
| VSTMVerastem, Inc. | COM | 19,974,658 | $2,816 萬 | 1.1% | +2,912,500+17.1% | 加碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 3,367,826 | $2,684 萬 | 1.1% | +447,300+15.3% | 加碼 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 2,472,327 | $2,645 萬 | 1.1% | +598,995+32.0% | 加碼 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 1,616,665 | $2,436 萬 | 1.0% | +1,616,665 | 新進 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 3,695,629 | $2,284 萬 | 0.9% | +844,168+29.6% | 加碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,851,051 | $2,151 萬 | 0.9% | +220,000+3.3% | 加碼 | 歷史 |
| GBIOGeneration Bio Co. | COM | 2,802,950 | $2,057 萬 | 0.8% | +2,613,900+1,382.7% | 加碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 1,600,559 | $1,791 萬 | 0.7% | +1,600,559 | 新進 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 3,526,729 | $1,788 萬 | 0.7% | +568,922+19.2% | 加碼 | – |
| VIRXViracta Therapeutics, Inc. | COM | 3,614,662 | $1,721 萬 | 0.7% | +175,718+5.1% | 加碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,142,340 | $1,638 萬 | 0.7% | +125,026+12.3% | 加碼 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,328,239 | $1,615 萬 | 0.6% | 00.0% | 不變 | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,755,545 | $1,575 萬 | 0.6% | +1,301,000+286.2% | 加碼 | 歷史 |
| REPLReplimune Group, Inc. | COM | 926,529 | $1,573 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 5,803,700 | $1,550 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| IMAImageneBio, Inc. | COM | 2,501,571 | $1,526 萬 | 0.6% | +703,200+39.1% | 加碼 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 879,085 | $1,492 萬 | 0.6% | −20,307−2.3% | 減碼 | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 955,000 | $1,456 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| CFRXCONTRAFECT Corp | COM NEW | 3,972,300 | $1,450 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,589,495 | $1,426 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 4,046,735 | $1,396 萬 | 0.6% | +917,136+29.3% | 加碼 | 歷史 |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $1,390 萬 | 0.6% | 00.0% | 不變 | – |
| SPROSpero Therapeutics, Inc. | COM | 1,585,615 | $1,380 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 666,666 | $1,267 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 2,861,851 | $1,156 萬 | 0.5% | +1,070,500+59.8% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,532,282 | $1,148 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $1,088 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NUVLNuvalent, Inc. | COM | 689,418 | $957.6 萬 | 0.4% | +240,906+53.7% | 加碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 2,326,710 | $916.7 萬 | 0.4% | +948,690+68.8% | 加碼 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 1,189,100 | $906.1 萬 | 0.4% | +1,166,900+5,256.3% | 加碼 | 歷史 |
| MOLNMolecular Partners AG | ADS | 443,221 | $898.4 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 809,282 | $802.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| IVAInventiva S.A. | ADS | 686,040 | $793.7 萬 | 0.3% | +141,540+26.0% | 加碼 | 歷史 |
| CNCEConcert Pharmaceuticals, Inc. | COM | 2,253,000 | $759.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| INFIInfinity Pharmaceuticals, Inc. | COM | 6,353,645 | $724.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 2,312,198 | $582.7 萬 | 0.2% | +700,500+43.5% | 加碼 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM | 6,861,127 | $571.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| GNCAGenocea Biosciences, Inc. | COM NEW | 4,012,404 | $501.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CALACalithera Biosciences, Inc. | COM | 9,294,923 | $375.5 萬 | 0.2% | +1,842,592+24.7% | 加碼 | 歷史 |
| Radius Health, Inc.750469207 | COM NEW | 378,000 | $333.8 萬 | 0.1% | +378,000 | 新進 | – |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,799,694 | $286.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RNTXRein Therapeutics, Inc. | COM | 5,265,555 | $269.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 432,892 | $251.5 萬 | 0.1% | 00.0% | 不變 | – |
| Erytech Pharma29604W108 | SPONSORED ADR | 1,314,656 | $239.3 萬 | 0.1% | 00.0% | 不變 | – |
| ELTXElicio Therapeutics, Inc. | COM | 1,071,297 | $227.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,370,947 | $224.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 3,532,057 | $212.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 1,723,133 | $211.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 847,879 | $148.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 289,663 | $113.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| JNCEJounce Therapeutics, Inc. | COM | 126,797 | $86.1 萬 | <0.1% | +126,797 | 新進 | 歷史 |
| BNOXBionomics Ltd | ADS | 80,971 | $69.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $64.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
2021 年第 4 季之後清倉（8 檔）
2021 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 4 季股數 | 2021 年第 4 季市值 | 2021 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| AMRNAmarin Corp PLC | SPONS ADR NEW | 16,459,965 | $5,547 萬 | 2.0% | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 1,800,000 | $2,936 萬 | 1.1% | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 435,936 | $695.3 萬 | 0.3% | 歷史 |
| Eucrates Biomedical Acqu CorG3141W114 | UNIT 10/23/2027 | 500,000 | $499.0 萬 | 0.2% | – |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 500,000 | $495.0 萬 | 0.2% | – |
| 5 01 Acquisition Corp33836P105 | COM CL A | 500,000 | $492.5 萬 | 0.2% | – |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $486.0 萬 | 0.2% | 歷史 |
| JYACJiya Acquisition Corp. | COM CL A | 300,000 | $293.1 萬 | 0.1% | 歷史 |